Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: Case Report and review of the literature

Pharmacotherapy

Volumn 29, Issue 5, 2009, Pages 608-612

  Goyal, Rakesh K ^a   Srivastava, Dimple ^b   Lessnau, Klaus Dieter ^a  

^a LENOX HILL HOSPITAL   (United States)

^b BROOKLYN HOSPITAL CENTER   (United States)

Author keywords

Adverse drug reactions; Clopidogrel; Hepatotoxicity; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMLODIPINE; CLOPIDOGREL; COLCHICINE; FERROUS SULFATE; LANSOPRAZOLE; LIVER ENZYME; METOPROLOL; OMEPRAZOLE; SIMVASTATIN; VALSARTAN;

AGED; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; DRUG ELUTING STENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART INFARCTION; HEPATITIS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFECTIOUS MONONUCLEOSIS; LIVER CELL DAMAGE; LIVER FUNCTION TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE JAUNDICE; PERCUTANEOUS CORONARY INTERVENTION; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL ENZYME TESTS; FEMALE; HUMANS; JAUNDICE, OBSTRUCTIVE; LIVER DISEASES; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 66249124628     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.5.608     Document Type: Article

References (36)

1. . Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.
2. . Ishak KG. Drug-induced liver injury pathology. In: Clinical and pathological correlations in liver disease: approaching the next millennium-postgraduate course. Alexandria, VA: American Association for the Study of Liver Diseases, 1998:236.
3. . Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003;349:474-85.
4. . Bissell DM, Gores GJ, Laskin DL, Hoofnagle JH. Druginduced liver injury: mechanisms and test systems. Hepatology 2001;33:1009-13.
5. . Chitturi S, George J. Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis 2002;22:169-83.
6. . Fuster V, Stein B, Ambrose JA, et al. Atherosclerotic plaque rupture and thrombosis: evolving concepts. Circulation 1990;82 (suppl):II47-59.
7. . Yusuf S, Zhao F, Mehta SR, et al, for the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
8. . Mehta SR, Yusuf S, Peters RJ, et al, for the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.
9. . Steinhubl SR, Berger PB, Mann JT III, et al, for the Clopidogrel for the Reduction of Events During Observation (CREDO) Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20. (Erratum in JAMA 2003;289:987.)
10. . Richter T, Murfter TE, Heinkele G, et al. Potent mechanismbased inhibition of human CYP2B6 by clopidogrel and ticlopidine. J Pharmacol Exp Ther 2004;308:189-97.
11. . Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Variability in individual responsiveness to clopidogrel: clinical implications, management and future perspectives. J Am Coll Cardiol 2007;49:1505-16.
12. . Bertrand ME, Rupprecht HJ, Urban P, et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102:624-9.
13. . Cadroy Y, Bossavy JP, Thalamas C, et al. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation 2000;101:2823-8.
14. . CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk for ischemic events (CAPRIE). Lancet 1996;348:1329-39.
15. . Oo TH. Clopidogrel-associated thrombotic thrombocytopenic purpura presenting with coronary artery thrombosis. Am J Hematol 2006;81:890-1.
16. . Comert A, Akgun S, Civelek A, et al. Clopidogrel-induced hypersensitivity syndrome associated with febrile pancytopenia. Int J Dermatol 2005;44:882-4.
17. . Wolf I, Mouallem M, Rath S, Farfel Z. Clopidogrel-induced systemic inflammatory response syndrome. Mayo Clin Proc 2003;78:618-20.
18. . Wiper A, Schmitt M, Roberts DH. Clopidogrel-induced hepatotoxicity [case report]. J Postgrad Med 2008;54:152.
19. . Ng JA, Goldberg N, Tafreshi MJ. Clopidogrel-induced hepatotoxicity and fever. Pharmacotherapy 2006;26:1023-6.
20. . Hollmuller I, Stadlman S, Graziadei I, Vogel W. Clinicohistopathological characteristics of clopidogrel-induced hepatic injury: case report and review of literature. Eur J Gastroenterol Hepatol 2006;18:931-4.
21. . Chau TN, Yim KF, Mok NS, et al. Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting. Hong Kong Med J 2005;11:414-16.
22. . Beltran-Robles M, Marquez Saavedra E, Sanchez-Munoz D, Romero-Gomez M. Hepatotoxicity induced by clopidogrel. J Hepatol 2004;40:560-2.
23. . Ramos Ramos JC, Sanz Moreno J, Calvo Carrasco L, Garcia Diaz Jde D. Clopidogrel-induced hepatotoxicity [in Spanish]. Med Clin (Barc) 2003;120:156-7.
24. . Duran Quintana JA, Jimenez Saenz M, Montero AR, Gutierrez MH. Clopidogrel probably induced hepatic toxicity [case report in Spanish]. Med Clin (Barc) 2002;119:37.
25. . Willens HJ. Clopidogrel-induced mixed hepatocellular and cholestatic liver injury. Am J Ther 2000;7:317-18.
26. . Lopez Vicente J, Garfia C, Lopez Medrano F, Yela C. Hepatic toxicity and clopidogrel-induced systemic inflammatory response syndrome. Revista Espanola de Cardiologia 2007;60:323-4.
27. . Batwa F, Lamoureaux E, Friedman G. Clopidogrel-induced liver injury [case report]. Can J Gastroenterol 2003;17:232.
28. . Anonymous.Clopidogrel-hepatitis and liver failure [in German]. Intern Pract 2008;48:606-7.
29. . Phillips EJ, Knowles SR, Shear NH. Serum sickness-like reaction associated with clopidogrel [case report]. Br J Clin Pharmacol 2003;56:583.
30. . Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997;26:664-9.
31. . Lata S, Chudy B. Acute cholestatic hepatitis caused by simvastatin in a 67-year-old patient [in Polish]. Przegl Lek 2006;63(suppl 7):97-8.
32. . El-Matary W, Dalzell M. Omeprazole-induced hepatitis. Pediatr Emerg Care 2005;21:529-30.
33. . Viana de Miguel C, Alvarez Garcia M, Sanchez Sanchez A, Carvajal Garcia-Pando A. Lansoprazole-induced hepatitis [case report in Spanish]. Med Clin (Barc) 1997;108:599.
34. . Larrey D, Henrion J, Heller F, et al. Metoprolol-induced hepatitis: rechallenge and drug oxidation phenotyping. Ann Intern Med 1988;108:67-8.
35. . Yoon JY, Min SY, Park JY, et al. A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis [in Korean]. Korean J Hepatol 2008;14:97-101.
36. . Kiykim A, Altintas E, Sezgin O, et al. Valsartan-induced hepatotoxicity in an HBs-Ag-positive patient [case report]. Am J Gastroenterol 2003;98:507.